帕金森病的药物恩塔卡通过铁分离破坏肠道微生物群的恒常性
Fátima C Pereira1,2, Xiaowei Ge3, Jannie Munk Kristensen1
1Centre for Microbiology and Environmental Systems Science, Department of Microbiology and Ecosystem Science, University of Vienna, Vienna, Austria.
bioRxiv : the preprint server for biology
|November 28, 2023
概括
两种常见的神经系统药物显著改变了肠道细菌的新陈代谢,而不仅仅是数字. 恩塔卡消耗铁,促进耐药微生物,揭示了药物诱导的微生物组破坏的新机制.
科学领域:
- 微生物组研究的研究.
- 药理学 药理学是指药理学的学科.
- 主体-微生物相互作用
背景情况:
- 针对人类的药物可以影响肠道微生物群,影响宿主健康.
- 药物与微生物群相互作用的机制和功能后果仍然不太清楚.
研究的目的:
- 研究恩塔卡和洛克萨酸盐对肠道微生物群的影响.
- 阐明药物诱导的微生物组变化的机制.
主要方法:
- 定量化微生物组概况分析
- 长时间阅读的元基因组学.
- 稳定同位素探测 稳定同位素探测
- 单细胞化学成像技术的使用
- 体样本分析 体样本分析
主要成果:
- 恩塔卡和洛克萨酸盐改变了多达三分之一的微生物物种的丰富性.
- 药物对微生物代谢的影响比丰富性更大,减少了关键物种的活性.
- 恩塔卡的机制涉及铁的复杂化和耗尽,影响微生物生长.
- 由安塔卡诱导的铁饥饿,为具有抗微生物耐药性和毒性基因的微生物选择.
结论:
- 药物诱导的金属封存是微生物组干扰的一个重要机制.
- 了解这些药物微生物群相互作用对于宿主健康至关重要.
- 恩塔卡和洛克萨酸盐对肠道微生物组功能有深远的影响.
相关概念视频
Parkinson's Disease: Treatment
276
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
276
Drugs Affecting GI Tract Motility: Adsorbents as Antidiarrheal Agents
221
Diarrhea is characterized by the occurrence of frequent, watery bowel movements. Various factors can trigger diarrhea, including viral or bacterial infections, foodborne illnesses, side effects from certain medications, and underlying digestive disorders. If not adequately managed, diarrhea can lead to complications such as dehydration, electrolyte imbalances, and nutrient deficiencies. Severe diarrhea can lead to significant weight loss, malnutrition, and weakened immune function.
Adsorbents...
Adsorbents...
221
Factors Influencing Drug Absorption: Disease States and Pharmacology
532
Multiple disease states can significantly influence the oral drug absorption process by affecting blood flow and the functionality of the gastrointestinal (GI) system. Various GI diseases, including conditions that alter GI motility, such as diarrhea, decreased acid secretions (achlorhydria), and infections, have been associated with reduced drug absorption.
Substances such as alcohol and specific drugs, including antineoplastics, can also negatively impact drug absorption. For instance,...
Substances such as alcohol and specific drugs, including antineoplastics, can also negatively impact drug absorption. For instance,...
532
Drugs Affecting GI Tract Motility: Serotonin Receptor Agonists
266
Serotonin, a crucial neurotransmitter synthesized by enterochromaffin cells, plays a cardinal role in regulating gastrointestinal (GI) motility. With over 90% of the body's total serotonin in the GI tract, its influence on digestive processes is profound. Serotonin is swiftly released upon various stimuli, such as food boluses or certain drugs, triggering intrinsic sensory neurons in the myenteric plexus and extrinsic vagal and spinal sensory neurons. This leads to the activation of the...
266
Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents
126
Acute diarrhea, a common gastrointestinal disturbance, is characterized by the rapid evacuation of fluid stools, leading to an excessive weight in fluid. This condition typically arises from disorders affecting intestinal water and electrolyte transport. It can be triggered by an increased osmotic load within the intestine, excessive secretion of electrolytes and water, mucosal exudation of protein and fluid, or altered intestinal motility. The primary risks of acute diarrhea are dehydration...
126
Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists
342
Prokinetic agents are specialized medications that stimulate gastrointestinal (GI) motility, promoting food movement through the GI tract. Dopamine, an inhibitory neurotransmitter, plays a significant role in this process, reducing GI motility and indirectly controlling the speed of digestion. Dopamine receptor antagonists, such as metoclopramide and domperidone, offer a unique advantage as prokinetic agents. By blocking the dopamine receptors, these drugs increase GI motility, improving food...
342


